Omnicell (OMCL) Notes Payables (2021 - 2025)
Omnicell (OMCL) reported Notes Payables of $174.8 million for Q2 2025, little changed on a QoQ basis from $174.6 million in Q1 2025.
Omnicell (OMCL) has 4 years of Notes Payables data on file, last reported at $174.8 million in Q2 2025.
- Quarterly Notes Payables changed N/A year-over-year to $174.8 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $174.8 million (changed N/A YoY) and the FY2024 annual result came in at $174.3 million, changed N/A from the prior year.
- Notes Payables steadied at $174.8 million in Q2 2025 per OMCL's latest filing, from $174.6 million in the prior quarter.
- Across five years, Notes Payables topped out at $572.0 million in Q3 2024 and bottomed at $174.3 million in Q4 2024.
- The 4-year median for Notes Payables is $331.5 million (2021), against an average of $358.0 million.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | Teladoc Health | 1.42 Bn | 672.39 Mn | 562.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 174.80 Mn |
| Mar 31, 2025 | 174.56 Mn |
| Dec 31, 2024 | 174.32 Mn |
| Sep 30, 2024 | 572.00 Mn |
| Mar 31, 2022 | 564.27 Mn |
| Dec 31, 2021 | 488.15 Mn |